We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
351
Dyne Therapeutics
DYN
$4.66B
$360K 0.01%
16,230
-6,771
-29% -$126K
COO icon
352
Cooper Companies
COO
$13.8B
$360K 0.01%
5,019
+108
+2% +$7.06K
BAX icon
353
Baxter International
BAX
$13.2B
$355K 0.01%
16,668
-2,551
-13% -$47.5K
WMB icon
354
Williams Companies
WMB
$90.6B
$355K 0.01%
4,780
+375
+9% +$27.6K
USB icon
355
US Bancorp
USB
$99B
$355K 0.01%
5,882
+217
+4% +$12.2K
TNGX icon
356
Tango Therapeutics
TNGX
$3.84B
$353K 0.01%
11,301
-1,893
-14% -$46.8K
DNLI icon
357
Denali Therapeutics
DNLI
$3.64B
$349K 0.01%
13,585
-5,357
-28% -$110K
HSIC icon
358
Henry Schein
HSIC
$10.1B
$347K 0.01%
4,159
-251
-6% -$19.2K
ZBH icon
359
Zimmer Biomet
ZBH
$18.9B
$345K 0.01%
4,008
-41
-1% -$3.6K
VCYT icon
360
Veracyte
VCYT
$3.59B
$344K 0.01%
5,849
-7,251
-55% -$304K
TYL icon
361
Tyler Technologies
TYL
$15.5B
$340K 0.01%
1,163
-23
-2% -$7.27K
FCX icon
362
Freeport-McMoran
FCX
$104B
$338K 0.01%
5,371
+140
+3% +$9K
IDYA icon
363
IDEAYA Biosciences
IDYA
$3.86B
$337K 0.01%
9,045
-1,852
-17% -$56.7K
PODD icon
364
Insulet
PODD
$10.4B
$336K 0.01%
2,208
+645
+41% +$107K
ZBRA icon
365
Zebra Technologies
ZBRA
$16.9B
$336K 0.01%
1,276
-85
-6% -$20K
UHS icon
366
Universal Health Services
UHS
$9.97B
$332K 0.01%
2,231
+383
+21% +$62.3K
ALGN icon
367
Align Technology
ALGN
$11.4B
$329K 0.01%
1,949
-62
-3% -$10.8K
TRMB icon
368
Trimble
TRMB
$14B
$324K 0.01%
6,328
– –
GD icon
369
General Dynamics
GD
$99B
$323K 0.01%
911
-12
-1% -$4.11K
RXRX icon
370
Recursion Pharmaceuticals
RXRX
$1.84B
$318K 0.01%
86,519
-25,431
-23% -$84.7K
SOLV icon
371
Solventum
SOLV
$15.7B
$317K 0.01%
4,110
-989
-19% -$72.1K
SRPT icon
372
Sarepta Therapeutics
SRPT
$2.43B
$313K 0.01%
17,435
-3,018
-15% -$57.1K
RCUS icon
373
Arcus Biosciences
RCUS
$3.84B
$312K 0.01%
10,113
-4,360
-30% -$108K
BX icon
374
Blackstone
BX
$103B
$310K 0.01%
2,634
-121
-4% -$14.5K
MMM icon
375
3M
MMM
$86.8B
$310K 0.01%
1,912
-72
-4% -$10.9K
13 14
15
16 17

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.